FDA to Observe 2020 Rare Disease Day

Article

FDA will observe Rare Disease Day on Feb. 29, 2020, with events surrounding the day’s 2020 theme, “Reframe Rare for Rare Disease Day.”

FDA will observe Rare Disease Day on Feb. 29, 2020, with events surrounding the day’s 2020 theme, “Reframe Rare for Rare Disease Day.”

Starting on Feb. 5, 2020, FDA has hosted the Beyond the Diagnosis Art Exhibit, a showcase of portraits of children with rare diseases, as part of Rare Disease Day, according to FDA’s website. The exhibit, which has traveled throughout the United States to various medical schools, research institutes, and hospitals, encourages attendees to look "beyond the diagnoses" of patients.

Additionally, on Feb. 24, FDA will host a public meeting where it will gather stakeholder’s opinions on rare disease product development and will work to pinpoint commonalities that support rare disease product development, according to the website. Portraits from the Beyond the Diagnosis Art Exhibit will be displayed during the meeting.

Source: FDA

 

 

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.